Literature DB >> 16033911

Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex.

Shintaro Fumoto1, Shigeru Kawakami, Kosuke Shigeta, Yuriko Higuchi, Fumiyoshi Yamashita, Mitsuru Hashida.   

Abstract

In this study, we evaluated the effect of blood components (whole blood and serum) on asialoglycoprotein receptor-mediated in vivo gene transfer. The hepatic transfection activity of galactosylated lipoplex preincubated with serum was approximately 10 times higher than that without incubation after intraportal injection in mice. However, preincubation with whole blood significantly reduced hepatic transfection activity. Fluorescent resonance energy transfer analysis and agarose gel electrophoresis revealed that preincubation with serum reduced the degree of destabilization of the galactosylated lipoplex in blood, partially supporting enhanced hepatic transfection activity by preincubation with serum. Inhibition of hepatic transfection activity by predosing galactosylated bovine serum albumin indicated that the galactosylated lipoplex exposed to serum is recognized by asialoglycoprotein-receptors on hepatocytes. Inactivation of serum prior to mixing with galactosylated lipoplex reduced liver accumulation and completely abolished enhancement of hepatic transfection activity by preincubation with active serum, suggesting that not only the stability of the lipoplex in blood but also the serum opsonin activity plays important roles. Alternatively, preincubation with inactivated serum reduced the lung accumulation and inflammatory cytokine production of galactosylated lipoplex. The information provided by this study will be valuable for the future use, design, and development of galactosylated lipoplex for in vivo asialoglycoprotein receptor-mediated gene transfer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033911     DOI: 10.1124/jpet.105.089516

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate.

Authors:  Kenneth J Longmuir; Sherry M Haynes; Janie L Baratta; Natasha Kasabwalla; Richard T Robertson
Journal:  Int J Pharm       Date:  2009-08-05       Impact factor: 5.875

2.  Physico-chemical characterization of polylipid nanoparticles for gene delivery to the liver.

Authors:  Maung T Nyunt; Christopher W Dicus; Yi-Yao Cui; M Cecilia Yappert; Thomas R Huser; Michael H Nantz; Jian Wu
Journal:  Bioconjug Chem       Date:  2009-11       Impact factor: 4.774

3.  Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice.

Authors:  Naoki Yoshikawa; Shintaro Fumoto; Keiko Yoshikawa; Die Hu; Kazuya Okami; Riku Kato; Mikiro Nakashima; Hirotaka Miyamoto; Koyo Nishida
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.